Mitoxantrone is a cancer drug also used in secondary progressive MS to slow progression and to extend the time between relapses in relapsing-remitting MS and progressive relapsing MS.
Read more...
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my MS progress | 125 |
|
|
|
|
|
20 |
| Other | 11 |
|
1 | ||||
| Support another treatment | 2 | 0 | |||||
| Multiple Sclerosis (MS) | 2 |
|
|
2 | |||
| Mobility | 2 |
|
1 | ||||
| disease-related symptoms | 1 | 0 |
Mouse over the table for more information
Top 10 dosages based on patients currently taking Mitoxantrone. See all 21 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Course of treatment ended
|
40 | 40% |
|
|
Doctor's advice
|
25 | 25% |
|
|
Did not seem to work
|
25 | 25% |
|
|
Side effects too severe
|
25 | 25% |
|
|
Other
|
12 | 12% |
|
|
Personal research
|
4 | 4% |
|
|
Not indicated
|
1 | 1% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.